[1] |
熊理守, 时权, 龚晓蓉, 等. 消化专科门诊肠易激综合征患者123例的临床特征与就医情况调查[J]. 中华消化杂志, 2015, (7):476-477.
|
[2] |
中华医学会消化病学分会胃肠功能性疾病协作组, 中华医学会消化病学分会胃肠动力学组. 2020年中国肠易激综合征专家共识意见[J]. 中华消化杂志. 2020,12(40):803-818.
|
[3] |
Gwee KA, Gonlachanvit S, Ghoshal UC, et al. Second Asian consensus on irritable bowel syndrome[J]. J Neurogastroenterol Motil, 2019,25(3):343-362.
doi: 10.5056/jnm19041
URL
|
[4] |
Mearin F, Lacy BE, Chang L, et al. Bowel disorders[J]. Gastroenterology, 2016,150(6):1393-1407.
doi: 10.1053/j.gastro.2016.02.031
URL
|
[5] |
Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors[J]. Nat Rev Gastroenterol Hepatol, 2020,17(8):473-486.
doi: 10.1038/s41575-020-0286-8
URL
|
[6] |
Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2020,5(10):908-917.
doi: 10.1016/S2468-1253(20)30217-X
URL
|
[7] |
Xiong LS, Chen MH, Chen HX, et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling[J]. Aliment Pharmacol Ther, 2004,19(11):1217-1224.
doi: 10.1111/apt.2004.19.issue-11
URL
|
[8] |
DuPont AW, Jiang ZD, Harold SA, et al. Motility abnormalities in irritable bowel syndrome[J]. Digestion, 2014,89(2):119-123.
doi: 10.1159/000356314
URL
|
[9] |
Zhang J, Song L, Wang Y, et al. Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats[J]. J Gastroenterol Hepatol, 2019,34(8):1368-1376.
doi: 10.1111/jgh.v34.8
URL
|
[10] |
Bai T, Xia J, Jiang Y, et al. Comparison of the Rome Ⅳ and Rome Ⅲ criteria for IBS diagnosis: A cross-sectional survey[J]. J Gastroenterol Hepatol, 2017,32(5):1018-1025.
doi: 10.1111/jgh.13642
URL
|
[11] |
Wang B, Zhao W, Zhao C, et al. What impact do Rome Ⅳ criteria have on patients with IBS in China?[J]. Scand J Gastroenterol, 2019,54(12):1433-1440.
doi: 10.1080/00365521.2019.1698650
URL
|
[12] |
Black CJ, Burr NE, Quigley EMM, et al. Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: Systematic review and network meta-analysis[J]. Gastroenterology, 2018,155(6):1753-1763.
doi: 10.1053/j.gastro.2018.08.021
URL
|
[13] |
Zheng L, Lai Y, Lu W, et al. Pinaverium reduces symptoms of irritable bowel syndrome in a multicenter, randomized, controlled trial[J]. Clin Gastroenterol Hepatol, 2015,13(7):1285-1292 e1281.
doi: 10.1016/j.cgh.2015.01.015
URL
|
[14] |
Black CJ, Thakur ER, Houghton LA, et al. Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis[J]. Gut, 2020,69(8):1441-1451.
doi: 10.1136/gutjnl-2020-321191
URL
|